Current Topics in Medicinal Chemistry

ISSN: 1568-0266 - Volume 8, 18 Issues, 2008

Editor-in-Chief:

Allen B. Reitz
Alsgen, Inc
One Deer Park Dr., Suite L-1
Monmouth Junction, NJ 08852
USA
Tel: +1- 215-264-4287
Email: reitz12000@yahoo.com

Associate Editor:

C. Lindsley
Vanderbilt University, Nashville, TN
USA

Editorial Advisory Board:

M.A. Abou-Gharbia (Wyeth Research, Princeton, NJ, USA)
J. Aube (Univ. of Kansas, Lawrence, KS, USA)
M. Avery (University of Mississippi, University, MS, USA)
B.N. Balasubramanian (Bristo-Myers Squibb, Princeton, NJ, USA)
T.R. Beattie (Consultant, San Diego, CA, USA)
D. Benjamin (AlsGen, Monmouth Junction, NJ)
P.R. Bernstein (AstraZeneca, Wilmington, DE, USA)
D.H. Boschelli (Wyeth Research, Pearl River, NY)
E. W. Baxter (Johnson & Johnson PRD, Spring House, PA USA)
G.W. Caldwell (Johnson & Johnson Pharmaceutical Res. & Devel., Spring House, PA, USA)
F.I. Carroll (Research Triangle Institute, Research Triangle Park, NC, USA)
N. Carruthers (Johnson & Johnson Pharmaceutical Res. & Devel., San Diego, CA, USA)
D. Comins (North Carolina State University, Raleigh, NC)
J.M. Cook (Univ. of Wisconsin, Milwaukee, WI, USA)
J. Cossy (ESPCOI, Paris, France)
G.I. Georg (Univ. of Minn, Lawrence, KS, USA)
C. Gilon (The Hebrew University, Jerusalem, Israel)
R. Giuliano (Villanova University, Villanova, PA USA)
R.A. Glennon (Virginia Commonwealth Univ., Richmond, VA, USA)
M.J. Green (Celera, South San Francisco, CA USA)
G. Hartman (Merck Research Labortories, West Point, PA, USA)
P.R. Hanson (Univ. of Kansas, Lawrence, KS, USA)
P.A. Hipskind (Lilly Research Laboratories, Indianapolis, IN, USA)
V.J. Hruby (Univ. of Arizona, Tucson, USA)
R.L. Hudkins (Cephalon, Inc., West Chester, PA, USA)
D. Huryn (University of Pennsylvania, Philadelphia, PA, USA)
K.A. Jacobson (National Institute of Health, Bethesda, MD, USA)
F. Janssens (Johnson & Johnson Pharmaceutical Res. & Devel., Beerse, Belgium)
A.D. Jordan (Johnson & Johnson Pharmaceutical Res. & Devel., Spring House, PA, USA)
M.M. Joullie (University of Pennsylvania, Philadelphia, USA)
E. Juaristi (CINVESTAV-IPN, Mexico, Mexico)
M.E. Jung (University of California Los Angeles, Lose Angels, CA, USA)
D. Kimball (Pharmacopeia Pharmaceuticals, Princeton, NJ, USA)
M. Koufaki (Institute of Organic and Pharmaceutical Chemistry, Athens, Greece)
A.P. Kozikowski (University of Illinois at Chicago, Chicago, IL, USA)
R.L. Li (Peking University, Beijing, China)
J.A. Lowe (Pfizer, Inc., Croton, CT, USA)
W.D. Lubell (Universite de Montreal, Montreal, Quebec, Canada)
M. Macielag (Johnson & Johnson Pharmaceutical Res. & Devel., Raritan, NJ, USA)
J.E. Macor (Bristol-Myers Squibb, Wallingford, CT, USA)
B.E. Maryanoff (Johnson & Johnson Pharmaceutical Res. & Devel., Spring House, PA, USA)
O.R. Martin (Universite d’Orleans, Orleans, France)
R. Mata (Facultad de Quimica, Univ. Nac. Auton. De Mexico, Mexico City, Mexico)
C.R. McCurdy (University of Mississippi, University, MS, USA)
D.D. Miller (University of Tennessee, Memphis, TN, USA)
G. Molander (University of Pennsylvania, Philadelphia, PA, USA)
M. Murcko (Vertex Pharmaceuticals, Cambridge, MA, USA)
R.P. Nargund (Merck Research Laboratories, Rahway, NJ, USA)
N. Neamati (Univ. of Southern California, Los Angels, CA, USA)
M.H. Norman (Amgen, Inc., Thousand Oaks, CA, USA)
I. Ojima (State University of New York, Stony Brook, NY, USA)
Z. Rankovic (Organon Research, Scotland, UK)
J. Regan (Boehringer Ingelheim, Ridgefield, CT)
J. A. Secrist, III (Southern Research Institute, Birmingham, AL, USA)
S.M. Sieburth (Temple University, Philadelphia, PA, USA)
B.B. Snider (Brandeis University, Waltham, MA, USA)
S. Street (Pfizer Global Res. & Devel., Sandwich, UK)
B. Tomczuk (Johnson & Johnson Pharmaceutical Res. & Devel., Spring House, PA, USA)
J.P. Vacca (Merck Research Laboratories, West Point, PA, USA)
L. Zhang (Peking University, Beijing, China)
N.Z. Zefirov (Moscow State University, Lenin Hills, Moscow, Russia)